Cannabis is also identified as weed, marijuana, pot, or ganja.
The drug also contains over a hundred cannabinoids — a chemical compound found within the plant.
The two main types of cannabinoids are tetrahydrocannabinol (THC), the psychoactive component of cannabis, which makes the person “high”, and cannabidiol (CBD), the non-psychoactive compound which is considered therapeutic.
Singapore’s stand on pharmaceutical cannabinoid product use:
In January 2018, Singapore’s (NRF) National Research Foundation said it would improve the artificial chemical compounds in the cannabis plant as part of a S$25 million deal into synthetic biology. Simultaneously, scientists expect to reveal the therapeutic capacity of these artificial cannabinoids.
Meanwhile, Singapore’s law against using unprocessed or raw cannabis, either claimed “medical” or recreational purposes, remained to be enforced. In a statement released on February 13, the Ministry of Home Affairs (MHA) and the Health Ministry (HM) said it was significant to distinguish amongst products covering raw cannabis or unprocessed and medical products containing cannabinoids.
The pharmaceuticals must go through “extreme scientific review” by the Health Sciences Authority before they can be given a license to supply the controlled drugs used for therapeutic purposes.
“Manufacturers are required to verify the quality, safety, and efficacy of the cannabinoid pharmaceuticals depending on scientific evidence from research studies and data on the mechanical process,” the ministries added. As of this time, pharmaceutical products with cannabinoids are not allowed in Singapore.
In December 2018, a girl who has refractory epilepsy was given approval by four Singapore authorities to be treated with the cannabis-based drugs. The first case of this kind. The permission was given after the young girl exhausted all medications and remained unsuccessful in responding to numerous treatments.
Associate Professor Derrick Chan, the President of the Singapore Epilepsy Society, mentioned that the drug requested is Epidiolex. It’s the first cannabis-derivative drug that has cannabidiol. Yet, cannabidiol neither causes euphoria or intoxication.
On June 25, 2018, the drug was allowed for severe and rare forms of epilepsy known as Dravet syndrome and Lennox-Gastaut syndrome for patients two years and older.
Cannabidiol skincare products: can it be used in Singapore legally?
Scientists are revealing evidence as to its effectiveness in treating psoriasis, dry skin, and eczema. Research is still being done to determine if it can aid with other inflammation-based skin conditions such as acne. In 2014, the United States National Library of Medicine found out that cannabidiol helps in repressing breakouts by regulating oil production of the sebaceous glands.
In Singapore, their law states that cannabis is considered a Class A controlled drug, where any possession, trafficking, consumption, and export or import of it is illegal. Any ingredient — including cannabidiol —is deemed illegal as well, that it may contain tetrahydrocannabinol (THC). Mascaras containing cannabis Sativa oil was confiscated in Singapore last year; even the beauty and wellness products having the ingredient were pulled out from the Sephora shelves.
For Singaporean residents interested in trying the other CBD beauty and skincare products, they can limit their use overseas until the policy on cannabidiol beauty products changes.
Photo grabbed from https://images.app.goo.gl/QcbBaFdu6CHHG7b76